Nano-enabled Drug Delivery Technologies: Players, products & prospects to 2015

Table of Contents

Executive Summary

• Competitor Ratio Analysis Summary

Introduction

Overview of nanotechnology: past, present & future

• Figure 1: Top ten applications of nanotechnology in developing countries
• Nanotechnology: motivators & resistors
  • Motivators
  • Resistors
• Nanotechnology: impact on product lifecycles

NANOTECHNOLOGY IN DRUG DELIVERY

• Core nanotechnology used by the pharma industry
  • Nano-engineered drugs
  • Nano-carriers
    • Figure 2: Dendrimer structure
    • Figure 3: Liposome structure
    • Figure 4: Micelle structure
• Current therapeutic application of nanotechnology in drug delivery
  • Leading brands that utilise nanotechnology delivery
    • Table 1: Nanotechnology-enabled approved drugs
• Future commercial applications & opportunities

STRATEGIES OF DRUG DELIVERY COMPANIES

• Leading nanotechnology drug delivery companies
  • Table 2: Leading nanotechnology-enabled drug delivery companies
• Partnerships & acquisitions
  • Strategic development & commercialisation partnerships and joint ventures
    • Table 3: Recent partnerships & acquisitions in the nanotechnology field
  • Mergers & acquisitions
    • Table 4: Nanotechnology patents

THE NANOTECHNOLOGY MARKET

• Now 2007
  • Table 5: Approved nano-enabled product sales
• Future 2015
  • Table 6: Novel nano-enabled product sales
  • Table 7: Global nano-enabled product sales

COMPETITOR ANALYSIS

• Movers & Shakers: Cutting edge or losing their grip
  • Table 8: Movers & shakers in nanotechnology drug delivery systems
• COMPANY PROFILES
  • Abraxis Bioscience
    • Table 9: Abraxis' product pipeline
    • Table 10: Abraxis Drug Delivery Sales
  • Access Pharmaceuticals
    • Table 11: Access Pharmaceuticals product pipeline
  • AlphaRx Corporation
    • Table 12: AlphaRx' product pipeline
    • Table 13: AlphaRx' pharmaceuticals drug delivery sales
  • ALZA Corporation
    • Table 14: ALZA' s drug delivery sales
  • BioSante Pharmaceuticals
    • Table 15: BioSante' s product pipeline
    • Table 16: BioSante' s drug delivery sales
  • Camurus AB
    • Table 17: Camurus AB' s product pipeline
    • Table 18: Camurus AB' s drug delivery sales
  • Eiffel Technologies
    • Table 19: Eiffel' s product pipeline
  • Elan Corporation
    • Table 20: Elan' s product pipeline
    • Table 21: Elan' s drug delivery sales
  • Eurand
    • Table 22: Eurand' s product pipeline
  • Gilead Sciences
    • Table 23: Gilead Sciences' product pipeline
    • Table 24: Gilead Sciences' drug delivery sales
  • Nano Interface Technology
    • Table 25: NITI' s product pipeline
  • Nano S Biotechnology GmbH
    • Table 26: Nano S' product pipeline
  • NanoBio Corporation
    • Table 27: NanoBio' s product pipeline
    • Table 28: NanoBio' s drug delivery sales
  • NanoBioMagnetics
    • Table 29: NanoBioMagnetics' product pipeline
  • Nanobiotix
    • Table 30: Nanobiotix' product pipeline
  • NanoCarrier
    • Table 31: NanoCarrier' s product pipeline
    • Table 32: NanoCarrier' s drug delivery sales
  • Nanotechnology Victoria, Ltd
    • Table 33: NanoVic' s product pipeline
  • NanoMaterials Technology
    • Table 34: NanoMaterial' s product pipeline
  • Nanotherapeutics
    • Table 35: Nanotherapeutics' product pipeline
    • Table 36: Nanotherapeutics' drug delivery sales
  • Novavax
    • Table 37: Novavax' s product pipeline
    • Table 38: Novavax' s drug delivery sales
  • SkyePharma
    • Table 39: SkyePharma' s product pipeline
    • Table 40: SkyePharma' s product sales
  • Spherics
    • Table 41: Spheric' s product pipeline

APENDIX 1

• Table 42: Global nanotechnology approved drugs sales 2006A-20015E

APENDIX 2

• Table 43: Global nanotechnology developmental drugs sales 2006A-20015E

APENDIX 3

• Competitor Ratio Analysis Criteria
  • Table 44: Key nanotechnology delivery companies by 2015

BIBLIOGRAPHY

GLOSSARY

ACRONYM S